Bionor appoints new CFO
This article was originally published in Scrip
Executive Summary
Oslo, Norway-based Bionor Pharma, a peptide vaccine company working in the area of HIV, has named Jens Krøis chief financial officer. Mr Krøis has more than 20 years' financial management experience across the Nordic regions and internationally. His previous roles include vice-president of business analysis at AMBU, a publicly listed Danish healthcare company, CFO of global customer service at FLSmidth & Co and executive CFO of Connection. Mr Krøis replaces chief operating officer Søren Keller, who had been serving as CFO in an interim role.